Results 11 to 20 of about 23 (22)

Mikronährstoffsupplemente bei onkologischen Patienten

Aktuelle Ernahrungsmedizin Klinik Und Praxis, 2011
Hans Konrad Biesalski
exaly  

Arzneimittel und Mikronährstoffe

Ernährung & Medizin, 2013
Uwe Grober
exaly  

Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS® MPH

European Child and Adolescent Psychiatry, 2005
A Rothenberger, Paramala Santosh, Remschmidt H   +2 more
exaly  

Comparative bioavailability and steady state fluctuations of tegretol commercial and carbamazepine oros tablets in adult and pediatric epileptic patients

Biopharmaceutics and Drug Disposition, 1992
Kamlesh M Thakker, William R Garnett, René H Levy   +2 more
exaly  

Exploring the Impact of Once-Daily OROS® Methylphenidate (MPH) on Symptoms and Quality of Life in Children and Adolescents with ADHD Transitioning from Immediate-Release MPH

Postgraduate Medicine, 2011
Fritz Mattejat
exaly  

OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: A randomized, placebo-controlled cross-over study

European Neuropsychopharmacology, 2014
Denise Bijlenga, Aartjan T F Beekman, J J Sandra Kooij   +2 more
exaly  

OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder

Expert Review of Neurotherapeutics, 2009
Josep Antoni Ramos-Quiroga, Xavier Castells, Rosa Bosch   +2 more
exaly  

Stable isotope methodology for studying the performance of metoprolol Oros tablets in comparison to conventional and slow release formulations

European Journal of Drug Metabolism and Pharmacokinetics, 1994
J Godbillon
exaly  

Gastric emptying of OROS tablets in man

International Journal of Pharmaceutics, 1984
exaly  

The clinical profile of children with ADHD that require OROS-methylphenidate combined with shorter-acting formulations

ADHD Attention Deficit and Hyperactivity Disorders, 2015
exaly